Using gait analysis to analyze Parkinson’s in rat model

Using gait analysis to analyze Parkinson’s in rat model

Posted by Gonny Smit on Thu 28 Jun. 2018 - 2 minute read

We all know Parkinson’s as the neurodegenerative disorder that affects mobility in a life-changing way. The slow movement, shuffling of the feet, and difficulties initiating movement are all bradykinesia signs that we recognize as typical for this disease.

Clinically relevant symptoms

So, why do most commonly used behavioral tests in animal research on Parkinson’s disease (PD) not actually assess behaviors that resemble these symptoms? That is what Jordi Boix and his colleagues from the University of Auckland in New Zealand asked themselves.

Parkinson’s model in rats

In their study, which was recently published in Frontiers in Behavioral Neuroscience, the researchers used two rat models of PD to investigate a number of gait parameters in hopes to find resemblance to human PD symptoms, and to specifically find them early on.

The rat model used in this study was a 6-OHDA lesion model as is common in many PD studies. Injection of 6-OHDA causes degeneration of the dopaminergic system causing effects in the brain similar to those observed in PD. The severity of the symptoms depend on the location of the injection, as it clinically does depending on the location of the cell death.

White rat in CatWalk rodent

In this study, placing this lesion in either medial forebrain bundle (MFB) or in the striatum resulted in two models with differing severity of symptoms. The MFB lesion had much more devastating effects.

Gait analysis method

To measure a range of gait parameters, the researchers used CatWalk XT gait analysis. Before each session, the animals were pre-trained. In combination with use of a goal box and some Cocopops®, this resulted in the collection of enough straight runs along the 70 cm glass plate to accurately acquire and assess gait and footprint parameters.

Parameters range

Using CatWalk XT, Boix assessed 21 gait parameters. General parameters such as average speed, but also dynamic paw parameters (stand phase, swing phase, etc.), coordination parameters (print position, phase dispersion, etc.), and static parameters like print area were measured.


The greatest impact the 6-OHDA lesion had was on average walking speed and cadence. Especially in the MFB lesion group, almost all gait disturbances the subjects showed paralleled human PD symptoms. Moving slowly in combination with reduced cadence and the altered swing phase reflected bradykinesia.

Also, the altered stand index, stride length, and print position mimic the typical small steps shown in PD patients.

Gait analysis as reliable method

Boix and his colleagues found gait analysis to be a reliable method for the detection of motor deficiencies relevant to PD. Particularly, it allowed for early detection, some as early as one week after the lesion was applied.

As the symptoms closely resemble clinical symptoms, the use of gait analysis can provide a valuable tool in the development of future therapeutic strategies for PD.


Boix, J.; von Hieber, D.; Connor, B. (2018). Gait Analysis for Early Detection of Motor Symptoms in the 6-OHDA Rat Model of Parkinson’s Disease. Frontiers in Behavioral Neuroscience, 12, 39.

Interested in reading more about CatWalk XT studies? 

RESOURCES: Read more about CatWalk XT

Find out how CatWalk XT is used in a wide range of studies and how it can elevate your research!

  • Free white papers and case studies
  • Customer success stories
  • Recent blog posts

Don't miss out on the latest blog posts
Share this post
Relevant Blogs

A 5-HT1A agonist and NMDA antagonist against Parkinson’s disease

Reducing side effects of L-Dopa with 5-HT1A receptor agonists can improve motor activity in a Parkinson’s disease model when combined with NMDA antagonists.

Zebrafish with Parkinson's

Parkinson’s Disease (PD) is one of the main neurodegenerative diseases and many researchers are involved in investigating this disease and developing treatments

New method for early detection of Alzheimer's disease

The color x-maze can be used to pick up symptoms of Alzheimer's disease in AD-mice months before traditional cognitive tests.